1013.80 5.05 (0.50%)
NSE Jun 06, 2023 15:57 PM
Volume: 1.6M
 

1013.80
0.50%
Sun Pharma may incur revenue loss for ransomware incident on March 2
Business Standard
Sun Pharma Advanced Research Company may incur expenses in connection with incident; India was the second most attacked country for ransomware in the APAC-Japan region in 2022
More from Sun Pharmaceutical Industries Ltd.
Recommended